• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贝叶斯修正雄性大鼠中全氟辛酸的渗透限制生理药代动力学模型。

Bayesian Refinement of the Permeability-Limited Physiologically Based Pharmacokinetic Model for Perfluorooctanoic Acid in Male Rats.

机构信息

Department of Civil and Environmental Engineering, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, United States.

Secondary Appointment, Department of Environmental and Occupational Health, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, United States.

出版信息

Chem Res Toxicol. 2021 Nov 15;34(11):2298-2308. doi: 10.1021/acs.chemrestox.1c00193. Epub 2021 Oct 27.

DOI:10.1021/acs.chemrestox.1c00193
PMID:34705448
Abstract

Physiologically based pharmacokinetic (PBPK) modeling is a powerful technique to inform risk assessment of xenobiotic substances such as perfluorooctanoic acid (PFOA). In our previous study, a permeability-limited PBPK model was developed to simulate the toxicokinetics and tissue distribution of PFOA in male rats. However, due to limited information on some key model parameters (, protein binding and active transport rates), the uncertainty of the permeability-limited PBPK model was quite high. To address this issue, a hierarchical Bayesian analysis with Markov chain Monte Carlo (MCMC) was applied to reduce the uncertainty of parameters and improve the performance of the PBPK model. With the optimized posterior parameters, the PBPK model was evaluated by comparing its prediction with experimental data from three different studies. The results show that the uncertainties of the posterior model parameters were reduced substantially. In addition, most of the PBPK model predictions were improved: with the posterior parameters, most of the predicted plasma toxicokinetics (, half-life) and tissue distribution fell well within a factor of 2.0 of the experimental data. Finally, the Bayesian framework could provide insights into the molecular mechanisms driving PFOA toxicokinetics: PFOA-protein binding, membrane permeability, and active transport.

摘要

生理药代动力学(PBPK)模型是一种强大的技术,可以为评估全氟辛酸(PFOA)等外源性物质的风险提供信息。在我们之前的研究中,开发了一个渗透限制的 PBPK 模型来模拟 PFOA 在雄性大鼠中的毒代动力学和组织分布。然而,由于一些关键模型参数(蛋白结合和主动转运速率)的信息有限,渗透限制的 PBPK 模型的不确定性非常高。为了解决这个问题,应用分层贝叶斯分析和马尔可夫链蒙特卡罗(MCMC)来降低参数的不确定性并提高 PBPK 模型的性能。使用优化后的后验参数,通过将其预测与来自三个不同研究的实验数据进行比较来评估 PBPK 模型。结果表明,后验模型参数的不确定性大大降低。此外,大多数 PBPK 模型的预测都得到了改善:在后验参数的情况下,大多数预测的血浆毒代动力学(半衰期)和组织分布都很好地落在实验数据的 2.0 倍以内。最后,贝叶斯框架可以深入了解驱动 PFOA 毒代动力学的分子机制:PFOA-蛋白结合、膜通透性和主动转运。

相似文献

1
Bayesian Refinement of the Permeability-Limited Physiologically Based Pharmacokinetic Model for Perfluorooctanoic Acid in Male Rats.贝叶斯修正雄性大鼠中全氟辛酸的渗透限制生理药代动力学模型。
Chem Res Toxicol. 2021 Nov 15;34(11):2298-2308. doi: 10.1021/acs.chemrestox.1c00193. Epub 2021 Oct 27.
2
A Permeability-Limited Physiologically Based Pharmacokinetic (PBPK) Model for Perfluorooctanoic acid (PFOA) in Male Rats.一种用于雄性大鼠全氟辛酸(PFOA)的渗透限制生理药代动力学(PBPK)模型。
Environ Sci Technol. 2017 Sep 5;51(17):9930-9939. doi: 10.1021/acs.est.7b02602. Epub 2017 Aug 18.
3
Comparing models for perfluorooctanoic acid pharmacokinetics using Bayesian analysis.使用贝叶斯分析比较全氟辛酸药代动力学模型
J Pharmacokinet Pharmacodyn. 2008 Dec;35(6):683-712. doi: 10.1007/s10928-008-9108-2. Epub 2009 Jan 8.
4
Evaluating parameter availability for physiologically based pharmacokinetic (PBPK) modeling of perfluorooctanoic acid (PFOA) in zebrafish.评估基于生理的药代动力学(PBPK)模型中全氟辛酸(PFOA)在斑马鱼中参数可用性。
Environ Sci Process Impacts. 2018 Jan 24;20(1):105-119. doi: 10.1039/c7em00474e.
5
Bayesian evaluation of a physiologically based pharmacokinetic (PBPK) model for perfluorooctane sulfonate (PFOS) to characterize the interspecies uncertainty between mice, rats, monkeys, and humans: Development and performance verification.基于生理学的药代动力学(PBPK)模型评估全氟辛烷磺酸(PFOS)在小鼠、大鼠、猴子和人类之间的种间不确定性:开发和性能验证。
Environ Int. 2019 Aug;129:408-422. doi: 10.1016/j.envint.2019.03.058. Epub 2019 May 29.
6
Sex, age, and species differences of perfluorooctanoic acid modeled by flow- versus permeability-limited physiologically-based pharmacokinetic models.通过基于生理药代动力学模型的流量限制模型与通透性限制模型对全氟辛酸的性别、年龄和物种差异进行建模。
Toxicology. 2024 Jun;505:153806. doi: 10.1016/j.tox.2024.153806. Epub 2024 Apr 18.
7
Influence of the uncertainty in the validation of PBPK models: A case-study for PFOS and PFOA.生理药代动力学(PBPK)模型验证中的不确定性影响:全氟辛烷磺酸(PFOS)和全氟辛酸(PFOA)的案例研究
Regul Toxicol Pharmacol. 2016 Jun;77:230-9. doi: 10.1016/j.yrtph.2016.03.009. Epub 2016 Mar 15.
8
Physiologically based pharmacokinetic modeling of human exposure to perfluorooctanoic acid suggests historical non drinking-water exposures are important for predicting current serum concentrations.基于生理的人体全氟辛酸暴露药代动力学模型表明,历史上非饮用水暴露对于预测当前血清浓度很重要。
Toxicol Appl Pharmacol. 2017 Sep 1;330:9-21. doi: 10.1016/j.taap.2017.07.001. Epub 2017 Jul 3.
9
PBPK modeling for PFOS and PFOA: validation with human experimental data.全氟辛烷磺酸和全氟辛酸的生理药代动力学建模:基于人体实验数据的验证
Toxicol Lett. 2014 Oct 15;230(2):244-51. doi: 10.1016/j.toxlet.2014.01.007. Epub 2014 Jan 17.
10
Formation of PFAAs in fish through biotransformation: A PBPK approach.通过生物转化在鱼类中形成全氟羧酸:一种 PBPK 方法。
Chemosphere. 2018 Jul;202:218-227. doi: 10.1016/j.chemosphere.2018.03.064. Epub 2018 Mar 15.

引用本文的文献

1
Estimation of species- and sex-specific PFAS pharmacokinetics in mice, rats, and non-human primates using a Bayesian hierarchical methodology.使用贝叶斯分层方法估计小鼠、大鼠和非人灵长类动物中特定物种和性别的全氟烷基和多氟烷基物质(PFAS)药代动力学。
Toxicol Appl Pharmacol. 2025 Jun;499:117336. doi: 10.1016/j.taap.2025.117336. Epub 2025 Apr 8.
2
Effects of PFAS on human liver transporters: implications for health outcomes.全氟和多氟化合物(PFAS)对人肝脏转运蛋白的影响:对健康结果的启示。
Toxicol Sci. 2024 Aug 1;200(2):213-227. doi: 10.1093/toxsci/kfae061.
3
Exploring Route-Specific Pharmacokinetics of PFAS in Mice by Coupling Tests and Physiologically Based Toxicokinetic Models.
通过结合测试和基于生理的毒代动力学模型探索 PFAS 在小鼠中的途径特异性药代动力学。
Environ Health Perspect. 2023 Dec;131(12):127012. doi: 10.1289/EHP11969. Epub 2023 Dec 13.
4
A State-of-the-Science Review of Interactions of Per- and Polyfluoroalkyl Substances (PFAS) with Renal Transporters in Health and Disease: Implications for Population Variability in PFAS Toxicokinetics.关于全氟和多氟烷基物质(PFAS)与健康和疾病中的肾脏转运蛋白相互作用的科学综述:对 PFAS 毒代动力学中人群变异性的影响。
Environ Health Perspect. 2023 Jul;131(7):76002. doi: 10.1289/EHP11885. Epub 2023 Jul 7.